Clinical Trial Update: Ketoconazole as Inhibitor of the Enzyme CYP17 in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary [Phase 2]

View source ↗

Summary

A phase 2 trial evaluated ketoconazole as a CYP17 inhibitor in locally advanced or disseminated granulosa cell tumor of the ovary; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulosa Cell Tumor of the Ovary

Drugs mentioned

• Ketoconazole (Ketoconazole)

Snippet

Sponsor: Grupo Español de Tumores Huérfanos e Infrecuentes | Conditions: Granulosa Cell Tumour of the Ovary | Phase 2 | Status: TERMINATED